WHO ICTRP trial

A randomized controlled trial of colistin combined with sulbactam: 9 g per day…

TCTR20190623002 · Thai Clinical Trials Registry (TCTR) · Recruiting

Key facts

Trial ID TCTR20190623002
Public title A randomized controlled trial of colistin combined with sulbactam: 9 g per day versus 12 g per day in the treatment of extensively drug-resistant resistant Acinetobacter baumannii pneumonia
Scientific title Clinical outcome in treatment of MDR A.baumannii pneumonia treated with colistin combined with high dose sulbactam : A randomized control trial
Primary sponsor Department of Medicine, Phramongkutklao Hospital
Registry Thai Clinical Trials Registry (TCTR)
Recruitment status Recruiting
Study type Interventional
Phase Phase 4
Countries Thailand
Conditions Extensively drug resistance Acinetobacter baumannii pneumonia XDR A. baumannii, colistin, high dose sulbactam;XDR A. baumannii, colistin, high dose sulbactam
Interventions Give colistin combined with sulbactam 9-g/d ,Give colistin combined with sulbactam 12-g/d;Experimental Drug,Experimental Drug;Colistin combined with sulbactam 9-g/d,Colistin combined with sulbactam 12-g/d
Registration date Jun 23, 2019
Target size 138
Secondary IDs Nil Known
Registry page thaiclinicaltrials.org

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations